Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, KMS Medisurgi's average Book Value per Share Growth Rate was 2.80% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 4.80% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 5.60% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 8.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of KMS Medisurgi was 75.60% per year. The lowest was 1.60% per year. And the median was 6.25% per year.
KMS Medisurgi (BOM:540468) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
KMS Medisurgi 3-Year Book Growth Rate Related Terms
BOM:540468 vs ISRG, BDX, MDLN: 3-Year Book Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 4.80% mean?
KMS Medisurgi (BOM:540468) has a 3-Year Book Growth Rate of 4.80% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for KMS Medisurgi and its competitors. This is 23% below median its historical median of 6.25. Over the past decade, KMS Medisurgi's 3-Year Book Growth Rate has ranged from 1.60 to 75.60.
Is KMS Medisurgi's 3-Year Book Growth Rate too high?
KMS Medisurgi's current 3-Year Book Growth Rate of 4.80% is 23% below median its 10-year median of 6.25. Over the past 10 years, this metric has ranged from a low of 1.60 to a high of 75.60. The Medical Devices & Instruments industry median 3-Year Book Growth Rate is 2.30. KMS Medisurgi's value of 4.80% is 108.7% above this industry median. Overall, KMS Medisurgi has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's 3-Year Book Growth Rate compare to ISRG and BDX?
KMS Medisurgi's 3-Year Book Growth Rate of 4.80% can be compared against companies in the Medical Devices & Instruments industry. The industry median 3-Year Book Growth Rate is 2.30. KMS Medisurgi's value of 4.80% is 108.7% above this benchmark. Historically, KMS Medisurgi's own 3-Year Book Growth Rate has ranged from 1.60 to 75.60 over the past decade. While the company's 10-year median is 6.25 vs. the industry median of 2.30, KMS Medisurgi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.30, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current 3-Year Book Growth Rate of 4.80% is 108.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current 3-Year Book Growth Rate is 4.80%, which is 23% below median its own 10-year median of 6.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
KMS Medisurgi (BOM:540468) has a current 3-Year Book Growth Rate of 4.80%. The stock's GF Value™ is ₹111.52, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current 3-Year Book Growth Rate is 4.80%, which is 23% below median its 10-year median of 6.25 and 108.7% above the Medical Devices & Instruments industry median of 2.30. KMS Medisurgi's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current 3-Year Book Growth Rate is 4.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.52.
Key valuation signals for BOM:540468:
3-Year Book Growth Rate: 4.80% (23% below median its 10-year median of 6.25)
GF Value™: ₹111.52 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 108.7% above the Medical Devices & Instruments median
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
